Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Alzheimer's Disease

  Free Subscription


11.11.2019

2 Alzheimers Dement
1 BMC Neurol
2 Curr Alzheimer Res
8 J Alzheimers Dis
2 Nat Med
1 Nat Neurosci
2 Nat Rev Neurol
1 Neurobiol Aging
2 Neuroscience
3 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimers Dement

  1. PULINA MV, Hopkins M, Haroutunian V, Greengard P, et al
    C99 selectively accumulates in vulnerable neurons in Alzheimer's disease.
    Alzheimers Dement. 2019 Oct 30. pii: S1552-5260(19)35370.
    PubMed     Text format     Abstract available

  2. ISAACSON RS, Hristov H, Saif N, Hackett K, et al
    Individualized clinical management of patients at risk for Alzheimer's dementia.
    Alzheimers Dement. 2019 Oct 31. pii: S1552-5260(19)35368.
    PubMed     Text format     Abstract available


    BMC Neurol

  3. ZHANG YR, Ding YL, Chen KL, Liu Y, et al
    The items in the Chinese version of the Montreal cognitive assessment basic discriminate among different severities of Alzheimer's disease.
    BMC Neurol. 2019;19:269.
    PubMed     Text format     Abstract available


    Curr Alzheimer Res

  4. MCLARNON JG
    Consideration of a Pharmacological Combinatorial Approach to Inhibit Chronic Inflammation in Alzheimer's Disease.
    Curr Alzheimer Res. 2019 Nov 5. pii: CAR-EPUB-102125.
    PubMed     Text format     Abstract available

  5. MOYSE E, Haddad M, Benlabiod C, Ramassamy C, et al
    Common Pathological Mechanisms and Risk Factors for Alzheimer's Disease and Type-2 Diabetes: Focus on Inflammation.
    Curr Alzheimer Res. 2019 Nov 5. pii: CAR-EPUB-102124.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  6. MASSA F, Farotti L, Eusebi P, Capello E, et al
    Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190539. doi: 10.3233/JAD-190539.
    PubMed     Text format     Abstract available

  7. GATT A, Whitfield DR, Ballard C, Doherty P, et al
    Alzheimer's Disease Progression in the 5xFAD Mouse Captured with a Multiplex Gene Expression Array.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190805. doi: 10.3233/JAD-190805.
    PubMed     Text format     Abstract available

  8. POZUETA A, Lage C, Garcia-Martinez M, Kazimierczak M, et al
    Cognitive and Behavioral Profiles of Left and Right Semantic Dementia: Differential Diagnosis with Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190877. doi: 10.3233/JAD-190877.
    PubMed     Text format     Abstract available

  9. WANG ZJ, Zhao F, Wang CF, Zhang XM, et al
    Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190796. doi: 10.3233/JAD-190796.
    PubMed     Text format     Abstract available

  10. ABDULLAH M, Kimura N, Akatsu H, Hashizume Y, et al
    Flotillin is a Novel Diagnostic Blood Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190908. doi: 10.3233/JAD-190908.
    PubMed     Text format     Abstract available

  11. AL RIHANI SB, Lan RS, Kaddoumi A
    Granisetron Alleviates Alzheimer's Disease Pathology in TgSwDI Mice Through Calmodulin-Dependent Protein Kinase II/cAMP-Response Element Binding Protein Pathway.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190849. doi: 10.3233/JAD-190849.
    PubMed     Text format     Abstract available

  12. DOWJAT K, Adayev T, Wojda U, Brzozowska K, et al
    Abnormalities of DYRK1A-Cytoskeleton Complexes in the Blood Cells as Potential Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190475. doi: 10.3233/JAD-190475.
    PubMed     Text format     Abstract available

  13. CHRISTL J, Verhulsdonk S, Pessanha F, Menge T, et al
    Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190550. doi: 10.3233/JAD-190550.
    PubMed     Text format     Abstract available


    Nat Med

  14. ZALOCUSKY KA, Nelson MR, Huang Y
    An Alzheimer's-disease-protective APOE mutation.
    Nat Med. 2019 Nov 4. pii: 10.1038/s41591-019-0634.
    PubMed     Text format    

  15. ARBOLEDA-VELASQUEZ JF, Lopera F, O'Hare M, Delgado-Tirado S, et al
    Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.
    Nat Med. 2019 Nov 4. pii: 10.1038/s41591-019-0611.
    PubMed     Text format     Abstract available


    Nat Neurosci

  16. FECHER C, Trovo L, Muller SA, Snaidero N, et al
    Cell-type-specific profiling of brain mitochondria reveals functional and molecular diversity.
    Nat Neurosci. 2019;22:1731-1742.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  17. LEMPRIERE S
    Changes in network synchronization herald Alzheimer Disease.
    Nat Rev Neurol. 2019 Nov 6. pii: 10.1038/s41582-019-0288.
    PubMed     Text format    

  18. BABAPOUR MOFRAD R, van der Flier WM
    Nature and implications of sex differences in AD pathology.
    Nat Rev Neurol. 2019;15:6-8.
    PubMed     Text format    


    Neurobiol Aging

  19. WOHLERS I, Schulz C, Kilpert F, Bertram L, et al
    Alzheimer's disease risk SNPs show no strong effect on miRNA expression in human lymphoblastoid cell lines.
    Neurobiol Aging. 2019 Aug 20. pii: S0197-4580(19)30291.
    PubMed     Text format     Abstract available


    Neuroscience

  20. VOSOUGHI A, Sadigh-Eteghad S, Ghorbani M, Shahmorad S, et al
    Mathematical Models to Shed Light on Amyloid-Beta and Tau Protein Dependent Pathologies in Alzheimer's Disease.
    Neuroscience. 2019 Nov 1. pii: S0306-4522(19)30662.
    PubMed     Text format     Abstract available

  21. CHATTERJEE M, Teunissen C
    Contactins & Alzheimer's disease Synaptic proteins, contactins may contribute to the pathology of Alzheimer's disease.
    Neuroscience. 2019 Nov 1. pii: S0306-4522(19)30741.
    PubMed     Text format    


    PLoS One

  22. GOFRIT ON, Klein BY, Cohen IR, Ben-Hur T, et al
    Bacillus Calmette-Guerin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients.
    PLoS One. 2019;14:e0224433.
    PubMed     Text format     Abstract available

  23. YOUSSIF KA, Haggag EG, Elshamy AM, Rabeh MA, et al
    Anti-Alzheimer potential, metabolomic profiling and molecular docking of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea aqueous extracts.
    PLoS One. 2019;14:e0223781.
    PubMed     Text format     Abstract available

  24. KIM JI, Kang BH
    Decreased retinal thickness in patients with Alzheimer's disease is correlated with disease severity.
    PLoS One. 2019;14:e0224180.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  25. PARK MH, Lee M, Nam G, Kim M, et al
    N,N'-Diacetyl-p-phenylenediamine restores microglial phagocytosis and improves cognitive defects in Alzheimer's disease transgenic mice.
    Proc Natl Acad Sci U S A. 2019 Nov 4. pii: 1916318116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: